0

Rhythm Disorders and Devices Collection
 1-20 of 610 Articles
Reviews |  5 March 2013
Cognitive Impairment Associated With Atrial Fibrillation: A Meta-analysis
Shadi Kalantarian, MD, MPH; Theodore A. Stern, MD; Moussa Mansour, MD; et al.
Ann Intern Med. 2013;158(5_Part_1):338-346. doi:10.7326/0003-4819-158-5-201303050-00007
Reviews |  4 December 2012
Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism: A Systematic Review
Soheir S. Adam, MD; Jennifer R. McDuffie, PhD; Thomas L. Ortel, MD, PhD; et al.
Ann Intern Med. 2012;157(11):796-807. doi:10.7326/0003-4819-157-10-201211200-00532
Original Research |  16 October 2012
Reuse of Explanted, Resterilized Implantable Cardioverter-Defibrillators: A Cohort Study
Behzad B. Pavri, MD; Yash Lokhandwala, MBBS, DM; Gaurav V. Kulkarni, MD; et al.
Ann Intern Med. 2012;157(8):542-548. doi:10.7326/0003-4819-157-8-201210160-00004
Editorials |  16 October 2012
Reuse of Medical Devices and Global Health Equity
Paul Farmer, MD, PhD; Gene Bukhman, MD, PhD
Ann Intern Med. 2012;157(8):591-592. doi:10.7326/0003-4819-157-8-201210160-00015
Original Research |  3 July 2012
Improving the Efficiency of Advanced Life Support Training: A Randomized, Controlled Trial
Gavin D. Perkins, MD; Peter K. Kimani, PhD; Ian Bullock, PhD; et al.
Ann Intern Med. 2012;157(1):19-28. doi:10.7326/0003-4819-157-1-201207030-00005
Editorials |  3 July 2012
Advanced Life Support Training: Does Online Learning Translate to Real-World Performance?
Steven J. Yule, PhD; Ron M. Walls, MD
Ann Intern Med. 2012;157(1):69-70. doi:10.7326/0003-4819-157-1-201207030-00013
Ideas and Opinions |  3 July 2012
Dabigatran: Uncharted Waters and Potential Harms
Ryan P. Radecki, MD
Ann Intern Med. 2012;157(1):66-68. doi:10.7326/0003-4819-157-1-201207030-00467
Original Research |  7 February 2012
Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database
Derek R. MacFadden, MD; Eugene Crystal, MD; Andrew D. Krahn, MD; et al.
Ann Intern Med. 2012;156(3):195-203. doi:10.7326/0003-4819-156-3-201202070-00007
Editorials |  7 February 2012
Is Biology Destiny or Can We Optimize Care for All Patients?
Pamela S. Douglas, MD; Lesley H. Curtis, PhD
Ann Intern Med. 2012;156(3):241-242. doi:10.7326/0003-4819-156-3-201202070-00015
Original Research |  15 November 2011
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
Jonas Oldgren, MD, PhD; Marco Alings, MD, PhD; Harald Darius, MD, PhD; et al.
Ann Intern Med. 2011;155(10):660-667. doi:10.7326/0003-4819-155-10-201111150-00004
Editorials |  15 November 2011
Learning the Respective Roles of Warfarin and Dabigatran to Prevent Stroke in Patients With Nonvalvular Atrial Fibrillation
Rebecca J. Beyth, MD; C. Seth Landefeld, MD
Ann Intern Med. 2011;155(10):714-715. doi:10.7326/0003-4819-155-10-201111150-00012
Original Research |  1 November 2011
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
Stuart J. Connolly, MD; John W. Eikelboom, MBBS; Jennifer Ng, MSc; et al.
Ann Intern Med. 2011;155(9):579-586. doi:10.7326/0003-4819-155-9-201111010-00004
Original Research |  1 November 2011
Safety of Screening Procedures With Hand-Held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices: A Cross-sectional Analysis
Clemens Jilek, MD; Stylianos Tzeis, MD, PhD; Hrvoje Vrazic, MD, PhD; et al.
Ann Intern Med. 2011;155(9):587-592. doi:10.7326/0003-4819-155-9-201111010-00005
Editorials |  1 November 2011
Selecting the Optimal Stroke Prevention Therapy in Atrial Fibrillation
Margaret C. Fang, MD, MPH
Ann Intern Med. 2011;155(9):636-637. doi:10.7326/0003-4819-155-9-201111010-00014
Original Research |  4 October 2011
A Prospective Evaluation of a Protocol for Magnetic Resonance Imaging of Patients With Implanted Cardiac Devices
Saman Nazarian, MD; Rozann Hansford, RN, MPH; Ariel Roguin, MD, PhD; et al.
Ann Intern Med. 2011;155(7):415-424. doi:10.7326/0003-4819-155-7-201110040-00004
Editorials |  4 October 2011
Magnetic Resonance Imaging and Cardiac Devices: How Safe Is Safe Enough?
Matthew R. Reynolds, MD, MSc; Peter Zimetbaum, MD
Ann Intern Med. 2011;155(7):470-472. doi:10.7326/0003-4819-155-7-201110040-00010
Original Research |  4 January 2011 FREE
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
James V. Freeman, MD, MPH; Ruo P. Zhu, BA; Douglas K. Owens, MD, MSc; et al.
Ann Intern Med. 2011;154(1):1-11. doi:10.7326/0003-4819-154-1-201101040-00289
Original Research |  7 December 2010 FREE
Metoprolol Versus Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery: A Randomized Trial
Jari Halonen, MD; Pertti Loponen, MD; Otso Järvinen, MD, PhD; et al.
Ann Intern Med. 2010;153(11):703-709. doi:10.7326/0003-4819-153-11-201012070-00003
Reviews |  2 November 2010
Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators
Pasquale Santangeli, MD; Luigi Di Biase, MD; Antonio Dello Russo, MD; et al.
Ann Intern Med. 2010;153(9):592-599. doi:10.7326/0003-4819-153-9-201011020-00009
Editorials |  17 August 2010 FREE
Toward More Uniform Conflict Disclosures: The Updated ICMJE Conflict of Interest Reporting Form
Jeffrey M. Drazen, MD; Peter W. de Leeuw, MD, PhD; Christine Laine, MD, MPH, Editor; et al.
Ann Intern Med. 2010;153(4):268-269. doi:10.7326/0003-4819-153-4-201008170-00261
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)